about
The effect of palifermin on chemotherapyand radiation therapy-induced mucositis: a review of the current literatureImpact of correction of anemia on clinical outcome in patients with cancer: recent data from head and neck and breast cancer trials.Inhibiting substance p pathway for prevention of chemotherapy-induced emesis: preclinical data, clinical trials of neurokinin-1 receptor antagonists.Novel thrombopoetin mimetic agents with potential to ameliorate chemotherapy-induced thrombocytopenia.The role of methadone in the treatment of moderate to severe cancer pain.Recent developments in cancer pain assessment and management.Oral complications and management considerations in patients treated with high-dose chemotherapy.Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome.The management of bone loss in patients with breast or prostate cancer.Health-related quality of life in treatment for prostate cancer: looking beyond survival.Benefits of GM-CSF Versus Placebo or G-CSF in Reducing Chemotherapy-Induced Complications: A Systematic Review of the Literature.Optimizing management of tumor lysis syndrome in adults with hematologic malignancies.Impact of severe acute respiratory syndrome on patient access to palliative radiation therapy.Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myeloma.Management of hot flashes in men with prostate cancer being treated with androgen deprivation therapy.Hot flash therapies in breast cancer survivors.Catheter-related thrombosis: a critical review.Mucositis management in patients with cancer.Role of prophylactic antibiotics in the prevention of infections after chemotherapy: a literature review.Adverse effects of bevacizumab and their management in solid tumors.Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancer.Sunshine and rash: testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash.Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting.Topiramate in the treatment of neuropathic pain in patients with cancer.Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year.Supportive care aspects of vertebroplasty in patients with cancer.What is the evidence for implantable drug delivery systems for refractory cancer pain?Patient expectation of the partial response and response shift in pain score.Reasons for poor accrual in palliative radiation therapy research studies.Group medical appointments: organization and implementation in the bone marrow transplantation clinic.Every-three-week erythropoietic support during chemotherapy for cancer: current status and future issues.Highlights from: Third Annual Future of Supportive Therapy in Oncology, San Francisco, CA; 27th Annual, San Antonio Breast Cancer Symposium, San Antonio, TX; 46th Annual Meeting of the American Society of Hematology, San Diego, CA.Approaches to management of invasive fungal infections in patients with hematologic malignancies.Highlights from: The 2nd Annual Future of Supportive Therapy in Oncology; St. Kitts, West Indies.Unique aspects of supportive care using monoclonal antibodies in cancer treatment.Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program.Dehydroepiandrosterone for the treatment of hot flashes: a pilot study.Level of Concordance Between Proxy and Cancer Patient Ratings in Brief PainInventory.
P1433
Q28287379-2DAE1F3D-4643-4194-A6E9-A386F2AA48BEQ31162580-E8561E33-F84B-4B8B-992C-96016B64474FQ31162584-B2BC5FE3-B781-475B-B48E-4FD219EA8B7FQ33380368-E97552B9-AC76-4C4F-86E4-3097DF8237B8Q34594269-BCAAEC45-4AB6-47B6-9651-839BF976B4E8Q34594274-FB622DFC-E537-403B-98C8-7C42BCEFDA1AQ34796306-BC704A3E-E1E9-418F-A9F8-74CDAB80165FQ34796774-9B80C5EA-A274-448D-8FF7-D2FB1A3F61FBQ34796786-2602F549-856D-4395-A720-A7F322D4262BQ34796798-D5AEAC0A-A49E-4D92-9FE9-EF108CB50E78Q37217035-1B59E18B-1B00-4642-943F-71808CC907CBQ37217039-62163FBE-D7B4-4A2E-971A-7EEFA6B87F2BQ37217042-48690C25-7F44-48A9-905E-9B66497C8760Q37217046-82B0077E-FDB5-49F6-B6D2-8BAE6AE0E392Q37217050-16297B80-A85F-4D35-8A9E-8158B745CD55Q37218450-7D8CF11D-2C60-4247-9E49-52F315898E67Q37218454-1B9DA06C-0B26-4A4C-B133-5523B8E84E00Q37218457-F1476F7C-7315-4825-B461-24BDBBCC1D1AQ37218462-624E6C1B-B72F-4F4F-A2A3-7AA1447C1B39Q37218465-1F648ED9-2CF8-4E9A-A20A-B909DEFC743CQ37218469-1D08613E-137E-4538-8295-AACB1C7DB100Q37218472-2D183965-FF71-4E48-9CDE-127E6C7A7B90Q37218475-84EA477B-D17C-4880-A53C-047BA80C5317Q37218476-D82AD44C-D570-4BB1-8D5D-5084E2050B83Q37218481-599E6AC3-7C29-42B6-ADC8-7347D23FE586Q39317054-5A088318-D367-47C7-9858-895A997706D3Q39317060-955D3E3F-25C6-47D9-BE3E-189D3FC6E59FQ39317130-8E085E3B-2668-4B8D-9E58-0BF48A64332EQ39317137-EEF959A4-1038-43DE-AE44-5751803CB836Q40069988-56D9F652-C485-4C9E-8F0A-1185159587D5Q40069995-2E39BA78-C455-40B4-B8D4-43E84E07137BQ40070004-546F36BB-73A6-40C3-8AE7-F344A0F14A57Q40070011-7A095EC8-D4C6-4048-AB1E-455DB09B23EEQ40070676-CFC7C7E2-5B17-405E-8120-694DC9D6CC92Q40070681-74B6B45F-96B4-499E-99C8-104E48AE1B87Q40070686-D7075C23-AD80-44F9-9938-3AA580CDEAA6Q40414276-96E55AEC-5AD4-46C7-83DA-E5E1D6ED3EA5Q42662172-F7FDE618-9347-424D-A096-F0454C3756BEQ43484022-FE91BCC3-F87A-479D-B999-F13B59667AFFQ43690839-A3315A1F-FB49-445C-A801-65DCCA7E4D9C
P1433
description
revista científica
@es
rivista scientifica
@it
scholarly journal
@en
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Supportive Cancer Therapy
@ast
Supportive Cancer Therapy
@en
Supportive Cancer Therapy
@es
Supportive cancer therapy
@nl
type
label
Supportive Cancer Therapy
@ast
Supportive Cancer Therapy
@en
Supportive Cancer Therapy
@es
Supportive cancer therapy
@nl
altLabel
Support Cancer Ther
@en
prefLabel
Supportive Cancer Therapy
@ast
Supportive Cancer Therapy
@en
Supportive Cancer Therapy
@es
Supportive cancer therapy
@nl
P3181
P1055
P1156
4100151616
P1476
Supportive cancer therapy
@en